DTSQU has entered into a definitive Business Combination Agreement with PrimeGen US, Inc. on February 2, 2026, marking a significant milestone for this SPAC.
This represents the culmination of DTSQU's search for a target company, with the business combination agreement being the most material development for any SPAC. The company now has a clear liquidation deadline of October 26, 2026, creating urgency for shareholders to evaluate the proposed merger with PrimeGen US.
The financial picture shows significant deterioration in the company's balance sheet, with total assets declining 74.7% from $70.9M to $18.0M and cash & equivalents falling nearly 100% from $411K to just $461. Current liabilities surged 308% while stockholders' equity became increasingly negative, dropping to -$1.1M. Despite these concerning balance sheet trends, the company generated higher net income of $2.1M (up 78.7%) driven primarily by increased interest income, though operating losses doubled, reflecting the typical cash burn pattern of a SPAC approaching its business combination deadline.
Current liabilities surged 308.3% — significant near-term obligations; verify ability to meet short-term debt.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Operating cash flow fell 108.9% — earnings quality concerns; investigate working capital changes and non-cash items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Cash declined 99.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Net interest income grew 84.3% — benefiting from rate environment or loan book expansion.
Current assets declined 78.8% — monitor working capital adequacy and short-term liquidity.
Net income grew 78.7% — bottom-line growth signals improving overall business health.
Total assets contracted 74.7% — asset sales, write-downs, or balance sheet optimization underway.
Liabilities grew 43% — significant increase in debt or obligations, assess impact on financial flexibility.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →